Investments (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Investments [Abstract] |
|
| Schedule Of Long Term Investments |
The following table summarizes the changes in the Company’s investments during the six months ended June 30, 2026 and year ended December 31, 2025:
|
|
|
|
|
|
|
June 30, 2026 |
|
December 31, 2025 |
|
|
(in thousands) |
Beginning |
$ |
32,720 |
$ |
43,578 |
Additions |
|
— |
|
432 |
Proceeds |
|
(69) |
|
(150) |
Fair value adjustments |
|
(2,304) |
|
(10,998) |
Transfers and other |
|
— |
|
(142) |
Ending |
$ |
30,347 |
$ |
32,720 |
The following table summarizes the change in fair value associated with the Company's equity investments and notes receivable instruments during the three and six months ended June 30, 2026 and 2025:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2026 |
|
2025 |
|
|
2026 |
|
2025 |
|
(in thousands) |
Equity investments |
$ |
(1,304) |
$ |
— |
|
$ |
(1,304) |
$ |
— |
Notes receivable instruments |
|
(1,000) |
|
— |
|
|
(1,000) |
|
— |
Accrued interest on notes receivable instruments |
|
— |
|
25 |
|
|
— |
|
50 |
Net fair value gains (losses) |
$ |
(2,304) |
$ |
25 |
|
$ |
(2,304) |
$ |
50 |
|
| Schedule of Change in Fair Value of Company's Investments |
The following table summarizes the change in fair value associated with the Company's equity investments and notes receivable instruments during the three and six months ended June 30, 2026 and 2025:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2026 |
|
2025 |
|
|
2026 |
|
2025 |
|
(in thousands) |
Equity investments |
$ |
(1,304) |
$ |
— |
|
$ |
(1,304) |
$ |
— |
Notes receivable instruments |
|
(1,000) |
|
— |
|
|
(1,000) |
|
— |
Accrued interest on notes receivable instruments |
|
— |
|
25 |
|
|
— |
|
50 |
Net fair value gains (losses) |
$ |
(2,304) |
$ |
25 |
|
$ |
(2,304) |
$ |
50 |
|
| Schedule of equity investments |
The following table summarizes the change in the Company's Level 3 equity investments during the three and six months ended June 30, 2026 and 2025:
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2026 |
|
2025 |
|
|
2026 |
|
2025 |
|
(in thousands) |
Beginning |
$ |
29,775 |
$ |
36,487 |
|
$ |
29,775 |
$ |
36,487 |
Additions |
|
— |
|
400 |
|
|
— |
|
400 |
Fair value adjustments |
|
(1,304) |
|
— |
|
|
(1,304) |
|
— |
Ending |
$ |
28,471 |
$ |
36,887 |
|
$ |
28,471 |
$ |
36,887 |
|
| Schedule of notes receivable instrument investments |
The following table summarizes the change in the Company's Level 3 notes receivable instruments during the three and six months ended June 30, 2026 and 2025.
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
|
|
2026 |
|
2025 |
|
|
2026 |
|
2025 |
|
(in thousands) |
Beginning |
$ |
2,889 |
$ |
6,974 |
|
$ |
2,945 |
$ |
7,091 |
Proceeds |
|
(13) |
|
(50) |
|
|
(69) |
|
(50) |
Fair value adjustments |
|
(1,000) |
|
— |
|
|
(1,000) |
|
— |
Accrued interest |
|
— |
|
25 |
|
|
— |
|
50 |
Transfers and other |
|
— |
|
— |
|
|
— |
|
(142) |
Ending |
$ |
1,876 |
$ |
6,949 |
|
$ |
1,876 |
$ |
6,949 |
|